A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 247.74
GOOG 1.110.71
MSFT 149.70
FB 156.79
BAC 21.60

Recently Added

CLOU 14.69
SEDG 82.37
CLVS 7.13
CODX 9.15
RLLCF 0.00

Gaining Speed

SEDG 82.37
CLVS 7.13
CODX 9.15
CLOU 14.69
ADXS 0.56

Clovis Oncology Announces Availability and Reimbursement for Rubraca® (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in Spain

Rubraca® (rucaparib) offers a new monotherapy maintenance treatment option for eligible women with relapsed, platinum-sensitive ovarian cancer, who harbor either a BRCA1/2 mutation or are BRCA wild-type Rucaparib provided statistically significant improvement in progression-free survival (PFS) versus placebo in all ovarian cancer patients...

Read More




Get Alerted When News Hits On This Stock - FREE!